<PAGE>
UNITED STATES
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 1995
COMMISSION FILE NO. 33-17966-LA
XANTHIC ENTERPRISES, INC.
A Colorado Corporation EIN: 94-3030021
8833 Sunset Blvd., Suite 200
West Hollywood, CA 90069 (310-289-4947)
Securities to be registered under Section 12(g) of the Act:
Common Shares and Series A and Series B
Common Stock Purchase Warrants
The registrant has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding period.
Aggregate market value. There is no market value as the Company's stock is not
trading currently.
As of December 31, 1995 there were 5,481,826 shares of Common Stock outstanding.
<PAGE>
PART I
ITEM 1. DESCRIPTION OF BUSINESS.
(1) The Company. Xanthic Enterprises, Inc. was incorporated in Colorado on
October 27, 1986 and has not yet commenced operations. The primary activity of
the Company will involve seeking merger or acquisition candidates.
(2) Plan of Operations. The Company plans to seek merger or acquisition
candidates.
(3) Employees. At the present time the Company has no employees other
than its officers. The officers devote as much time as they deem appropriate to
the Company's business. The officers are not paid salary or expenses.
(4) Administrative Offices. The Company maintains its executive offices at
8833 Sunset Blvd., Suite 200, West Hollywood, CA 90069 pursuant to an oral lease
agreement with David Lilly, a shareholder of the Company on a month to month
basis. No rent is paid for this office at this time.
ITEM 2. PROPERTIES.
The Company owns no properties, plans or other real estate, and has no
Letters of Intent to purchase or acquire any property.
ITEM 3. LEGAL PROCEEDINGS.
On November 2, 1991 the State of Oregon issued a cease and desist order
ordering the Company to cease and desist issuing unregistered securities in the
State of Oregon. The proceeding was based on the distribution of shares and
warrants to Oregon shareholders (registered by way of a S-18 registration
statement) pursuant to the agreement for such distribution between the Company
and Automated Services, Inc.
On April 2, 1992 the State of Oregon issued a final order to cease and
desist violating any provision of Oregon Securities Law. Xanthic was denied
the use of any statutory exemption provided in ORS 59.022 and ORS 59.035.
Xanthic, Mark Lilly and Glenn DeCicco were assessed civil penalties of $ 750.00
each for violating ORS 59.055 and ORS 59.132(2). Directors Mark Lilly and
Glenn DeCicco were ordered to cease and desist violating any provision of ORS
Chapter 59. Neither the Company nor the Directors appealed.
The Company has been advised that the effect of the Oregon ruling was to
2
<PAGE>
invalidate the issuance and distribution of the registered shares and warrants
to residents of Oregon until such time as said securities are registered
pursuant to the provisions of the Oregon Securities Law.
The number of shares affected by the ruling is estimated to be 188,000
shares owned by approximately 650 residents of Oregon. The 188,000 shares
represent approximately 3.4% of the issued and outstanding shares of Xanthic.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
No matters were submitted to the shareholders during the year 1995.
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON STOCK AND RELATED STOCKHOLDER MATTERS.
There is no established public trading market for the common shares of the
Company.
ITEM 6. SELECTED FINANCIAL DATA.
This information is omitted as allowed by General Instruction 1 of Form
10-K as the information is adequately reflected in the certified financial
statements as set forth in Item 8.
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.
(1) LIQUIDITY. The Company has no cash assets and no liquidity.
(2) CAPITAL RESOURCES. The Company has no capital resources.
(3) RESULTS OF OPERATIONS. The Company has not operated during the past
fiscal year and there are no results of operations.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Attached one audited financial statements for the Company as of
December 31, 1995.
3
<PAGE>
XANTHIC ENTERPRISES, INC.
(A DEVELOPMENT STAGE COMPANY)
FINANCIAL STATEMENTS
DECEMBER 31, 1995 AND 1994
4
<PAGE>
CONTENTS
PAGE
AUDITOR'S REVIEW REPORT.................................................... 6
FINANCIAL STATEMENTS:
BALANCE SHEET............................................................ 7
STATEMENTS OF OPERATION.................................................. 8
STATEMENT OF STOCKHOLDERS' EQUITY........................................ 9
STATEMENTS OF CASH FLOWS................................................. 10
NOTES TO FINANCIAL STATEMENTS............................................11-12
5
<PAGE>
TO THE BOARD OF DIRECTORS AND
STOCKHOLDERS OF XANTHIC ENTERPRISES, INC.:
We have audited the accompanying balance sheets of Xanthic Enterprises, Inc. (a
development stage company) as of December 31, 1995 and 1994, and the related
statements of operations, stockholders' equity (deficit), and cash flows for the
years then ended and for the period from October 27, 1986 (inception), to
December 31, 1995. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Xanthic Enterprises, Inc. as of
December 31, 1995, and 1994, and the results of its operations and cash flows
for the years then ended and from October 27, 1986 (inception), to
December 31, 1995 in conformity with generally accepted accounting principles.
Harlan & Boettger, CPA's
San Diego, California
February 24, 1997
6
<PAGE>
XANTHIC ENTERPRISES, INC.
(A DEVELOPMENT STAGE COMPANY)
BALANCE SHEETS
<TABLE>
<CAPTION>
December 31,
----------------------------
1995 1994
-------- --------
<S> <C> <C>
ASSETS
CURRENT ASSETS:
Cash $ - $ -
--------- ---------
--------- ---------
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Accounts payable $ 13,154 $ 11,750
--------- ---------
STOCKHOLDERS' EQUITY (DEFICIT):
Common stock, $.0001 par value, 50,000,000
shares authorized, 5,481,826 shares issued
and outstanding 548 548
Additional paid in capital 11,651 11,651
Deficit accumulated during the development
stage (25,353) (22,320)
--------- ---------
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) (13,154) (11,750)
--------- ---------
$ - $ -
--------- ---------
--------- ---------
</TABLE>
The accompanying notes are an integral part of these financial statements.
7
<PAGE>
XANTHIC ENTERPRISES, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF OPERATIONS
<TABLE>
<CAPTION>
October 27, 1986
For the year ended (Inception) to
December 31, December 31, 1995
------------------------------ -----------------
1995 1994
---------- ----------
<S> <C> <C> <C>
REVENUES $ - $ - $ -
---------- ---------- ----------
OPERATING EXPENSES
General and administrative 1,197 1,205 17,961
---------- ---------- ----------
LOSS FROM OPERATIONS (1,197) (1,205) (17,961)
OTHER INCOME (EXPENSES)
Interest expense (207) (424) (6,627)
Aborted offering costs - - (17,066)
Debt relief - - 17,051
Penalty 750
---------- ---------- ----------
TOTAL OTHER INCOME (EXPENSES) (207) (424) (7,392)
---------- ---------- ----------
NET LOSS $ (1,404) $ (1,629) $ (25,353)
---------- ---------- ----------
---------- ---------- ----------
NET LOSS PER COMMON SHARE $ (.0003) $ (.0003) $ (.005)
---------- ---------- ----------
---------- ---------- ----------
WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING 5,481,826 5,481,826 5,481,826
---------- ---------- ----------
---------- ---------- ----------
</TABLE>
The accompanying notes are an integral part of these financial statements.
8
<PAGE>
XANTHIC ENTERPRISES, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)
<TABLE>
<CAPTION>
Common Stock Accumulated
------------------------- Paid in deficit during
Shares Amount Capital development stage Total
------ ------ ------- ----------------- ---------
<S> <C> <C> <C> <C> <C>
BALANCE, DECEMBER 31, 1993 5,481,826 $ 548 $11,651 $ (22,320) $ (10,121)
---------- --------- ------- --------- ---------
Net loss for year - - - (1,629) (1,629)
---------- --------- ------- --------- ---------
BALANCE, DECEMBER 31, 1994 5,481,826 $ 548 $11,651 $ (23,949) $ (11,750)
---------- --------- ------- --------- ---------
Net loss for year - - - (1,404) (1,404)
---------- --------- ------- --------- ---------
BALANCE, DECEMBER 31, 1995 5,481,826 $ 548 $11,651 $ (25,353) $ (13,154)
---------- --------- ------- --------- ---------
---------- --------- ------- --------- ---------
</TABLE>
The accompanying notes are an integral part of these financial statements.
9
<PAGE>
XANTHIC ENTERPRISES, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF CASH FLOWS
<TABLE>
<CAPTION>
October 27, 1986
For the year ended (Inception) to
December 31, December 31, 1995
------------------------------ -----------------
1995 1994
---------- ----------
<S> <C> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $ (1,404) $ (1,629) $ (25,353)
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
Debt relief - - -
Common stock issued for services - - 31
Changes in operating assets and liabilities:
Accounts payable 1,404 1,629 13,154
--------- -------- ---------
NET CASH USED IN (ABSORBED BY) OPERATING
ACTIVITIES - - (12,168)
--------- -------- ---------
CASH FLOWS FROM FINANCING ACTIVITIES
Sale of common stock - - 12,168
--------- -------- ---------
NET CASH PROVIDED BY FINANCING ACTIVITIES - - -
--------- -------- ---------
NET INCREASE (DECREASE) IN CASH - - -
CASH, BEGINNING OF PERIOD - - -
--------- -------- ---------
CASH, END OF PERIOD $ - $ - $ -
--------- -------- ---------
--------- -------- ---------
</TABLE>
The accompanying notes are an integral part of these financial statements.
10
<PAGE>
XANTHIC ENTERPRISES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 1995
A. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
ORGANIZATION
Xanthic Enterprises, Inc., a Colorado corporation, was incorporated October
27, 1986, and since its inception, the Company has been in the development
stage. The Company's primary intended activity is to engage in all aspects
of review and evaluation of private companies, partnerships, or sole
proprietorships for the purpose of completing mergers or acquisitions with
the Company, and to engage in mergers acquisitions with any or all
varieties of private entities.
The Company has had no operations since its inception except for expenses
related to maintaining the corporate status.
BASIS OF ACCOUNTING
The Company's policy is to use the accrual method of accounting and to
prepare and present financial statements which conform to generally
accepted accounting principles. The preparation of financial statements in
conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and reported amounts of
revenues and expenses during the reporting periods. Actual results could
differ from those estimates.
B. ACCOUNTS PAYABLE:
Accounts payable at December 31, 1995 represents amounts due the Company's
stock transfer agency, AST.
C. CAPITAL STOCK
The Company is authorized to issue 50,000,000 shares of common stock, with
a par value of $.0001 per share.
In May, 1989 the Company became obligated to distribute shares and warrants
to the shareholders of ASI pursuant to the S-18 registration statement.
The Company distributed 313,826 shares of stock and 627,652 warrants
pursuant to the agreement with ASI. The shares and warrants were delivered
at various dates between May of 1989 and February of 1990. This
distribution included 313,826 shares of common stock and one (1) Class A
Warrant and one (1) Class B Warrant with each share of stock distributed.
Each warrant allowed the holder to acquire an additional share of common
stock as follows: The Class A Warrant had an exercise price of $0.75 per
share and an expiration date of April 30, 1990. The Class B Warrant had an
exercise price of $1.50 per share and an expiration date of April 30, 1992.
No warrants were exercised.
11
<PAGE>
XANTHIC ENTERPRISES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 1995
(CONTINUED)
D. LITIGATION:
On November 2, 1991 the State of Oregon issued a cease and desist order
ordering the Company to cease and desist issuing unregistered securities in
the State of Oregon. The proceedings was based on the distribution of
shares and warrants to Oregon shareholders (registered by way of a S-18
registration statement) pursuant to the agreements for such distribution
between the Company and Automated Services, Inc.
On April 2, 1992 the State or Oregon issued a final order to cease and
desist violating any provision of Oregon Securities Law. Xanthic was
denied the use of any statutory exemption provided in ORS 59.022 and ORS
59.035. Xanthic, Mark Lilly and Glenn DeCicco were assessed civil
penalties of $750.00 each for violating ORS 59.055 and ORS 59.132(2).
Directors Mark Lilly and Glenn DeCicco were ordered to cease and
desist violating any provision of ORS Chapter 59. Neither the
Company nor the Directors appealed.
The Company has been advised that the effect of the Oregon ruling was to
invalidate the issuance and distribution of the registered shares and
warrants to residents of Oregon until such time as said securities are
registered pursuant to the provisions of the Oregon Securities Law. The
number of shares affected by the ruling is estimated to be 188,000 shares
owned by approximately 650 residents at Oregon. The 188,000 shares
represent approximately 3.4% of the issued and outstanding shares of
the Company.
12
<PAGE>
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURES
There is no disagreement with any prior accountant.
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.
Mark A. Lilly, President and a Director. Mr. Lilly, age 32, has been
President of Xanthic since inception. During 1988 he was President of NinHao
Enterprises, Inc., a Colorado corporation. NinHo Enterprises is no longer
active. Mr. Lilly was an Assistant Health Planner for the Alameda Health
Consortium from February 1987 to May, 1988. Since May, 1988 Mr. Lilly was
self employed as a free lance computer programer.
Glenn DeCicco, Vice-President, Secretary and a Director. Mr. DeCicco, age
35, was a Senior Vice President of Nin Hao Enterprises during 1988 and was
President of Land and Water Real Estate Company, an inactive development stage
real estate consultation company formed in 1987. Land and Water Real Estate
Company has no assets, income or employees.
John D. Lilly, Vice-President. Mr. Lilly, age 29, has been a free lance
computer consultant since 1994.
John Lilly and Mark Lilly are brothers.
ITEM 11. EXECUTIVE COMPENSATION.
During the past year the Company did not compensate any officer or
director. The Company has no plans to compensate any officer or director at the
present time.
13
<PAGE>
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.
<TABLE>
<CAPTION>
Title of Class Name and Address Amount and Nature Percent of Class
of Beneficial of Beneficial Owner
Owner
<S> <C> <C> <C>
Common Shares Mark Lilly* 1,165,000 21.2
8833 Sunset Blvd.
Suite 200
West Hollywood, CA 90069
Glenn DeCicco* 1,106,500 20.1
100 Long Brook Way
Suite 21
Pleasant Hill, CA 94523
Brett Hudelson 1,106,500 20.1
147 Central
Ashland, OR 97520
John D. Lilly* 263,000 4.7
8833 Sunset Blvd.
Suite 200
West Hollywood, CA 90069
David G. Lilly 1,000,000 18.2
8833 Sunset Blvd.
Suite 200
West Hollywood, CA 90069
</TABLE>
*The total number of shares owned by officers and directors is 2,534,500.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.
Not Applicable.
Item 14. Exhibits, Financial Statements and Schedules.
The Company incorporates by reference the exhibits filed with its
registration statement and the amendments thereto. There have been no 8-K
filings during the past year. Attached under Item 8 are audited financial
statements for the Company as of December 31, 1995.
14
<PAGE>
SIGNATURE
In accordance with Section 12 of the Securities Exchange Act of 1934, this
registrant caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized.
XANTHIC ENTERPRISES, INC.
Dated: 4/2/97
-------------------------------
By: /s/ Mark A. Lilly
----------------------------------
Mark A. Lilly, President, Director
and Chief Financial Officer
Dated: 4/2/97
-------------------------------
By: /s/ Glenn DeCicco
----------------------------------
Glenn DeCicco, Vice President and
Director
15
